AnalystBook Research · Company Intelligence

Lifevantage Corp

LFVNNasdaq

Built from Lifevantage Corp's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data

Lifevantage Corp: Revenue grew 14.2% to $229M from $200M. Net income grew 233.8% to $9.805M from $2.937M. Free cash flow grew 5.6% to $10.51M from $9.952M. Operating margin expanded 318 bps to 5.34%. Lifevantage Corp's annual comparison also shows stock compensation grew faster than revenue; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.

The read at a glance✓ Audited against SEC data
  • Growth — Revenue grew 14.2% to $229M from $200MOK
  • Profitability — Net income grew 233.8% to $9.805M from $2.937MOK
  • Cash flow — Free cash flow grew 5.6% to $10.51M from $9.952MOK
  • Margins — Operating margin expanded 318 bps to 5.34%OK
  • Accounting — Distress-range screen needs contextWatch
  • Insiders — 8 purchases and 4 salesOK

Business

We are dedicated to using technology to facilitate a streamlined approach for independent consultants to manage their businesses and sell our products.

Where the revenue comes from

Fiscal 2026, as Lifevantage Corp reports it. History and quarterly detail are in the app.

  • Protandim$82.0M
  • True Science Product Line$37.9M
  • Life Vantage Product Line$32.3M
  • AXIO Product Line$15.0M
  • Love Biome Product Line$9.1M

Leadership changes

From Lifevantage Corp's own filings, the day they're filed.

  • Ray Greer · CEO · appointmenteff. 2026-04-15
  • Michael Beindorff · CEO · departureeff. 2026-04-13
  • Steven R. Fife · Chief Executive Officer · departureeff. 2026-02-04

Latest filings

  • 10-K · Annual report2026-08-27
  • 8-K · Company announcement2026-08-27
  • 8-K · Company announcement2026-08-03
  • 10-Q · Quarterly report2026-05-06
  • 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Lifevantage Corp, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

See the full LFVN record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.